Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2002
08/29/2002US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight
08/29/2002US20020119512 Ups
08/29/2002US20020119510 Enzymatic polypeptide for use in screening bactericides
08/29/2002US20020119508 Hydrogen peroxide indicator employing enzyme and dye
08/29/2002US20020119507 Determination method of biological component and reagent kit used therefor
08/29/2002US20020119506 Genes encoding UMP kinase, methods for purifying UMP kinase and methods of characterizing UMP kinase
08/29/2002US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease
08/29/2002US20020119500 Multiplexed enzymatic assays
08/29/2002US20020119499 Detecting modulators of membrane protein activities; obtain membrane protein sample, incubtae with modulator, detect adjustment in membrane activity
08/29/2002US20020119498 Detection dimerizing test polypeptide; obtain population of genetically engineered cells, express vector, isolate cells expressing desired concentration of reporter molecule
08/29/2002US20020119491 Monitoring therapeutic levels of S-adenosylmethionine in fluid sample; obtain sample containing enzymatic polypeptides and glycine, measure concentration of preferential reaction products compare to s-adenosylmethionine
08/29/2002US20020119489 Butyrylcholinesterase variants and methods of use
08/29/2002US20020119486 Apparatus for use in the detection of preferential particles in liquids
08/29/2002US20020119485 Detect preferential particle in sample by luminescence; obtain sample, incubate with probes, irradiate, detect luminescence
08/29/2002US20020119484 Detection and measure of preferential messenger ribonucleic acid; isolate nucleotide sequences from sample, amplify, hybridize to microaray, incubate with probes, detect amount of amplicon hybridized to probe
08/29/2002US20020119483 Methods for detection of chloral hydrate in dichloroacetic acid
08/29/2002US20020119482 Microfluidic apparatus for use in high throughput screening for genomics and human therapeutics
08/29/2002US20020119481 Method and apparatus to identify small variations of biomolecules
08/29/2002US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele
08/29/2002US20020119478 Diagnosing cancer in humans; obtain urine sample, screen sample for cancer marker gene expression, evaluate for cancer
08/29/2002US20020119475 Detecting target nucleotide sequence in sample; obtain sample of nucleotide sequences, incubate with protective agent, detecting and recovering protected nucleic acids
08/29/2002US20020119474 Kit for use in the treatment of allergies
08/29/2002US20020119473 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer
08/29/2002US20020119472 Methods for disease diagnosis from stool samples
08/29/2002US20020119471 Diagnosing allergic contact dermatitis in humans; obtain cells, isolate nucleotide sequences coding interleukins, monitor expression of interleukin polypeptide
08/29/2002US20020119470 Apparatus for the detection of preferential nucleotide sequences in sample; for detection of bacterial infections
08/29/2002US20020119469 Detection of preferential variation in nucleotide sequence samples; obtain samples, incubate with probes, detect variation in hybridization profiles, detect nucleotide sequence variations
08/29/2002US20020119468 Accurately detecting preferential liver graft doner; obtain human tissue sample, determine genotype, the presence of preferred genotype indicates potential liver graft doner
08/29/2002US20020119464 Compositions and methods enabling a totally internally controlled amplification reaction
08/29/2002US20020119463 Prostate cancer markers
08/29/2002US20020119462 Molecular toxicology modeling
08/29/2002US20020119461 High fidelity polymerases and uses thereof
08/29/2002US20020119460 Prostate cancer gene
08/29/2002US20020119459 Optical sorting method
08/29/2002US20020119457 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide
08/29/2002US20020119456 Methods and compositions for determining the sequence of nucleic acid molecules
08/29/2002US20020119455 Methods and products for analyzing polymers
08/29/2002US20020119454 Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides
08/29/2002US20020119453 HO-1 as a diagnostic and prognostic test for dementing diseases
08/29/2002US20020119451 System and method for predicting chromosomal regions that control phenotypic traits
08/29/2002US20020119450 Fluorimetric detection system of a nucleic acid
08/29/2002US20020119449 Rna-dependent rna polymerase functioning preferably on rna matrix and promoter-dependent transcription process with said rna- dependent rna polymerase
08/29/2002US20020119448 Detecting preferential nucleotide sequences in sample; obtain sample of nucleotide sequence, incubate with primer, sequence, recoevr sequence products and compare to control
08/29/2002US20020119447 Non-a,non-b,non-c,non-c,non-d,non-e hepatitis reagents and methods for their use
08/29/2002US20020119445 Genetic engineering; prophylactic therapy
08/29/2002US20020119444 Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance
08/29/2002US20020119443 Screening preferential prodrugs for use in viral therapy; obtain target tissue, incubate with prodrug, monitor and evaluate prodrug activity in tissues
08/29/2002US20020119442 Approaches to identify genetic traits
08/29/2002US20020119441 Method of characterizing potential therapeutics by determining cell-cell interactions
08/29/2002US20020119439 Genetic assays for trinucleotide repeat mutations in eukaryotic cells
08/29/2002US20020119438 Method for determining viable cell count
08/29/2002US20020119155 Protein-protein interactions in neurodegenerative diseases
08/29/2002US20020119137 Useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass
08/29/2002US20020119121 Compositions and methods for inducing specific cytolytic T cell responses
08/29/2002US20020118296 Integrated multi-format audio/video production system
08/29/2002CA2799371A1 Optoelectronic detection system
08/29/2002CA2750033A1 Methods and probes for the detection of cancer
08/29/2002CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
08/29/2002CA2440008A1 Rat toxicologically relevant genes and uses thereof
08/29/2002CA2439235A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes
08/29/2002CA2439030A1 Magnetic resonance spectroscopy to identify and classify microorganisms
08/29/2002CA2438818A1 Rapid production of monoclonal antibodies
08/29/2002CA2438762A1 Model of transmissible spongiform encephalopathic (tse) disease
08/29/2002CA2438740A1 Drug metabolizing enzymes
08/29/2002CA2438668A1 Method of preparing yeast for fermentation test
08/29/2002CA2438550A1 A method of identifying differences between nucleic acid molecules
08/29/2002CA2438415A1 Pixel arrays
08/29/2002CA2438390A1 Methods of modifying eukaryotic cells
08/29/2002CA2438371A1 Histidine phosphatase interacting protein of 120 kd
08/29/2002CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002CA2438235A1 Neurotransmission-associated proteins
08/29/2002CA2437937A1 Method for identifying herbicidally active substances
08/29/2002CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
08/29/2002CA2437253A1 Improved method for detection of atp using modified luciferase resistant to detergents
08/29/2002CA2437033A1 Optoelectronic detection system
08/29/2002CA2436516A1 Pg-3 and biallelic markers thereof
08/29/2002CA2436206A1 Tissue-based water quality biosensors for detecting chemical warfare agents
08/29/2002CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same
08/29/2002CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
08/29/2002CA2433348A1 Detection of compounds that modulate inflammatory responses
08/28/2002EP1235073A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME
08/28/2002EP1235069A1 Biosensor
08/28/2002EP1235068A1 Biosensor
08/28/2002EP1234888A2 Mutation analysis by mass spectrometry using photolytically cleavable primers
08/28/2002EP1234887A1 Process for binding nucleic acids to a carrier
08/28/2002EP1234886A1 A method for detecting beta-1,6-glucan synthase activity
08/28/2002EP1234880A1 Novel protein tab2
08/28/2002EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
08/28/2002EP1234873A1 Indicator medium for the detection of contaminants in gene libraries
08/28/2002EP1234835A2 Assays for assessing ABeta-Tau Aggregation
08/28/2002EP1234188A2 Protein kinase regulation
08/28/2002EP1234187A2 Method, apparatus, media and signals for identifying associated cell signaling proteins
08/28/2002EP1234185A2 Pin1 as a marker for abnormal cell growth
08/28/2002EP1234184A2 Multiblot kinase analysis
08/28/2002EP1234182A2 Hybridization of target dna with immobilized nucleic acid analogs
08/28/2002EP1234180A2 A method for high throughput thermodynamic screening of ligands
08/28/2002EP1234175A2 Improvements in and relating to forensic investigations
08/28/2002EP1234060A2 Evaluating and predicting clinical outcomes by gene expression analysis
08/28/2002EP1234059A2 Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
08/28/2002EP1234058A2 Nucleic acid probe arrays